GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Adrb1 | affects binding | ISO | Adrb1 (Rattus norvegicus) | 6480464 | CTD | Labetalol binds to ADRB1 protein | PMID:11483288 PMID:2462161 | Adrb1 | decreases activity | ISO | ADRB1 (Homo sapiens) | 6480464 | CTD | Labetalol results in decreased activity of ADRB1 protein | PMID:2567112 | Adrb1 | increases activity | ISO | ADRB1 (Homo sapiens) | 6480464 | CTD | Labetalol results in increased activity of ADRB1 protein | PMID:12761341 | Adrb1 | multiple interactions | ISO | Adrb1 (Rattus norvegicus) | 6480464 | CTD | Labetalol binds to and results in decreased activity of ADRB1 protein; Labetalol inhibits the reaction [CGP 12177 binds to ADRB1 protein]; Labetalol inhibits the reaction [Dihydroalprenolol binds to ADRB1 protein] | PMID:11425575 PMID:2462161 | Adrb1 | multiple interactions | ISO | ADRB1 (Homo sapiens) | 6480464 | CTD | [Labetalol co-treated with ADRB1] results in increased abundance of Cyclic AMP; CGP 20712A inhibits the reaction [[Labetalol co-treated with ADRB1] results in increased abundance of Cyclic AMP]; CGP 20712A inhibits the reaction [Labetalol results in increased activity of ADRB1 protein] | PMID:12761341 | |
Go Back to source page | Continue to Ontology report |